Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trialThorsten Braun(Humboldt-Universität zu Berlin)BloodAugust 9, 201110.1182/blood-2011-05-352039Cited by 198SaveCiteExport RISWatch citationsRelated PapersPlacenta Percreta Presents with Neoangiogenesis of Arteries with Von Willebrand Factor-Negative Endothelium|Reproductive Sciences|2021|18Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML)|Biomedicines|2021|12